Pharmacotherapy options and drug development in managing periprosthetic joint infections in the elderly

References

• Lenander C, Bondesson A, Viberg N, et al. Effects of medication reviews on use of potentially inappropriate medications in elderly patients; a cross-sectional study in Swedish primary care. BMC Health Serv Res. 2018 Aug 7;18(1):616.
   PubMedGoogle Scholar
• He W, Goodkind D, Kowal PUS. Census bureau, international population reports, P95/16-1, An aging world: 2015. Washington, DC: U.S.: Government Publishing Office; 2016.
   Google Scholar
• NIH. World’s older population grows dramatically; 2016 [cited 2018 Oct 16th]; Available from: https://www.nih.gov/news-events/news-releases/worlds-older-population-grows-dramatically
   Google Scholar
• Nigam Y, Knight J, Bhattacharya S, et al. Physiological changes associated with aging and immobility. J Aging Res. 2012;2012: 468469.
   PubMedGoogle Scholar
• Reddy P, Gosavi D, Varma SK. An overview of geriatric pharmacology. J Basic Clin Pharm. 2012;4(4):25–29.
   Google Scholar
• De Angelis G, Mutters N, Minkley L, et al. Prosthetic joint infections in the elderly.Infection.2015 Dec;43(6):629–637.
   Web of Science ®Google Scholar
• Jm H, Helmick CG, Barbour KE, et al. Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015-2040. Arthritis Rheumatol. 2016 Jul;68(7):1582–1587.
   PubMed Web of Science ®Google Scholar
• van Schoor NM, Zambon S, Castell MV, et al. Impact of clinical osteoarthritis of the hip, knee and hand on self-rated health in six European countries: the European project on OSteoArthritis. Qual Life Res. 2016 Jun;25(6):1423–1432.
   PubMed Web of Science ®Google Scholar
• Shah AK, Celestin J, Parks ML, et al. Long-term results of total joint arthroplasty in elderly patients who are frail. Clin Orthop Relat Res. 2004;Aug(425):106–109.
   Google Scholar
• Higuera CA, Elsharkawy K, Klika AK, et al. 2010 Mid-America Orthopaedic Association Physician in Training Award: predictors of early adverse outcomes after knee and hip arthroplasty in geriatric patients. Clin Orthop Relat Res. 2011 May;469(5):1391–1400.
   PubMed Web of Science ®Google Scholar
• Kapadia BH, Berg RA, Daley JA, et al. Periprosthetic joint infection. Lancet. 2016 Jan 23;387(10016):386–394.
   PubMed Web of Science ®Google Scholar
• Huotari K, Peltola M, Jamsen E. The incidence of late prosthetic joint infections: a registry-based study of 112,708 primary hip and knee replacements. Acta Orthop. 2015 Jun;86(3):321–325.
   PubMed Web of Science ®Google Scholar
• Bianchi L, Galante C, Zagra L. The management of femoral bone stock in THA revision: indications and techniques. Hip Int. 2014 Oct 2;24(Suppl 10):S37–43.
   PubMedGoogle Scholar
• Kurtz SM, Ong KL, Lau E, et al. Impact of the economic downturn on total joint replacement demand in the United States: updated projections to 2021. J Bone Joint Surg Am. 2014 Apr 16;96(8):624–630.
   PubMedGoogle Scholar
• Kurtz SM, Ong KL, Schmier J, et al. Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am. 2007 Oct;89(Suppl 3):144–151.
   PubMed Web of Science ®Google Scholar
• Kurtz SM, Lau E, Watson H, et al. Economic burden of periprosthetic joint infection in the United States. J Arthroplasty. 2012 Sep;27(8 Suppl):61–5 e1.
   PubMed Web of Science ®Google Scholar
• Kunutsor SK, Whitehouse MR, Blom AW, et al. Patient-related risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis. PLoS One. 2016;11(3):e0150866.
   PubMed Web of Science ®Google Scholar
• Mears SC, Edwards PK. Bone and Joint Infections in Older Adults. Clin Geriatr Med. 2016 Aug;32(3):555–570.
   PubMed Web of Science ®Google Scholar
• Lenguerrand E, Whitehouse MR, Beswick AD, et al. Risk factors associated with revision for prosthetic joint infection after hip replacement: a prospective observational cohort study. Lancet Infect Dis. 2018 Sep;18(9):1004–1014.
   PubMed Web of Science ®Google Scholar
• Makary MA, Segev DL, Pronovost PJ, et al. Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg. 2010 Jun;210(6):901–908.
   PubMed Web of Science ®Google Scholar
• Diaz-Ledezma C, Higuera CA, Parvizi J. Success after treatment of periprosthetic joint infection: a delphi-based international multidisciplinary consensus. Clin Orthop Relat Res. 2013 Jul;471(7):2374–2382.
   PubMed Web of Science ®Google Scholar
• Kunutsor SK, Beswick AD, Whitehouse MR, et al. Debridement, antibiotics and implant retention for periprosthetic joint infections: a systematic review and meta-analysis of treatment outcomes. J Infect. 2018 Dec;77(6):479–488.
   PubMed Web of Science ®Google Scholar
• Tande AJ, Patel R. Prosthetic joint infection. Clin Microbiol Rev. 2014 Apr;27(2):302–345.
   PubMed Web of Science ®Google Scholar
• Gehrke T, Alijanipour P, Parvizi J. The management of an infected total knee arthroplasty. Bone Joint J. 2015 Oct;97-B(10 Suppl A):20–29.
   PubMedGoogle Scholar
• Wasielewski RC, Barden RM, Rosenberg AG. Results of different surgical procedures on total knee arthroplasty infections. J Arthroplasty. 1996 Dec;11(8):931–938.
   PubMed Web of Science ®Google Scholar
• Kunutsor SK, Whitehouse MR, Lenguerrand E, et al. Re-infection outcomes following one- and two-stage surgical revision of infected knee prosthesis: a systematic review and meta-analysis. PLoS One. 2016;11(3):e0151537.
   PubMed Web of Science ®Google Scholar
• Djuric M, Djonic D, Milovanovic P, et al. Region-specific sex-dependent pattern of age-related changes of proximal femoral cancellous bone and its implications on differential bone fragility. Calcif Tissue Int. 2010 Mar;86(3):192–201.
   PubMed Web of Science ®Google Scholar
• Osmon DR, Berbari EF, Berendt AR, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the infectious diseases society of America. Clin Infect Dis. 2013 Jan;56(1):e1–e25.
   PubMed Web of Science ®Google Scholar
• Pradier M, Robineau O, Boucher A, et al. Suppressive antibiotic therapy with oral tetracyclines for prosthetic joint infections: a retrospective study of 78 patients. Infection. 2018 Feb;46(1):39–47.
   PubMed Web of Science ®Google Scholar
• Prendki V, Sergent P, Barrelet A, et al. Efficacy of indefinite chronic oral antimicrobial suppression for prosthetic joint infection in the elderly: a comparative study. Int J Infect Dis. 2017;60:57–60.
   PubMed Web of Science ®Google Scholar
• Borrego F, Gleckman R. Principles of antibiotic prescribing in the elderly. Drugs Aging. 1997 Jul;11(1):7–18.
   PubMed Web of Science ®Google Scholar
• McCue JD. Antibiotic use in the elderly: issues and nonissues. Clin Infect Dis. 1999 Apr;28(4):750–752.
   PubMed Web of Science ®Google Scholar
• Adam HJ, Baxter MR, Davidson RJ, et al. Comparison of pathogens and their antimicrobial resistance patterns in paediatric, adult and elderly patients in Canadian hospitals. J Antimicrob Chemother. 2013 May;68(Suppl 1):i31–7.
   PubMed Web of Science ®Google Scholar
• Warren JW, Palumbo FB, Fitterman L, et al. Incidence and characteristics of antibiotic use in aged nursing home patients. J Am Geriatr Soc. 1991 Oct;39(10):963–972.
   PubMed Web of Science ®Google Scholar
• Chapman AL, Dixon S, Andrews D, et al. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. J Antimicrob Chemother. 2009;64(6):1316–1324.
   PubMed Web of Science ®Google Scholar
• Esposito S, Leone S, Noviello S, et al. Outpatient parenteral antibiotic therapy for bone and joint infections: an Italian multicenter study. J Chemother. 2007;19(4):417–422.
   PubMed Web of Science ®Google Scholar
• Creditor MC. Hazards of hospitalization of the elderly. Ann Intern Med. 1993;118(3):219–223.
   PubMed Web of Science ®Google Scholar
• Jin J, Sklar GE, Min Sen Oh V, et al. Factors affecting therapeutic compliance: a review from the patient‘s perspective. Ther Clin Risk Manag. 2008 Feb;4(1):269–286.
   PubMedGoogle Scholar
• Lora-Tamayo J, Euba G, Cobo J, et al. Short- versus long-duration levofloxacin plus rifampicin for acute staphylococcal prosthetic joint infection managed with implant retention: a randomised clinical trial. Int J Antimicrob Agents. 2016 Sep;48(3):310–316.
   PubMed Web of Science ®Google Scholar
• Stahlmann R, Lode H. Safety considerations of fluoroquinolones in the elderly: an update. Drugs Aging. 2010 Mar 1;27(3):193–209.
   PubMed Web of Science ®Google Scholar
• Prendki V, Zeller V, Passeron D, et al. Outcome of patients over 80 years of age on prolonged suppressive antibiotic therapy for at least 6 months for prosthetic joint infection. Int J Infect Dis. 2014;29:184–189.
   PubMed Web of Science ®Google Scholar
• Wouthuyzen-Bakker M, Nijman JM, Kampinga GA, et al. Efficacy of antibiotic suppressive therapy in patients with a prosthetic joint infection. J Bone Jt Infect. 2017;2(2):77–83.
   PubMedGoogle Scholar
• American-Geriatrics-Society-2015-Beers-Criteria-Update-Expert-Panel. American geriatrics society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015 Nov;63(11):2227–2246.
   PubMed Web of Science ®Google Scholar
• Wei L, MacDonald TM, Mackenzie IS. Co-prescription of co-trimoxazole and spironolactone in elderly patients. BMJ. 2011 Sep;12(343):d5656.
   Google Scholar
• Hamilton-Miller JM. Probiotics and prebiotics in the elderly. Postgrad Med J. 2004 Aug;80(946):447–451.
   PubMed Web of Science ®Google Scholar
• Ljungberg B, Nilsson-Ehle I. Pharmacokinetics of antimicrobial agents in the elderly. Rev Infect Dis. 1987 Mar;9(2):250–264.
   PubMedGoogle Scholar
• Pagano D, Freemantle N, Bridgewater B, et al. Social deprivation and prognostic benefits of cardiac surgery: observational study of 44 902 patients from five hospitals over 10 years. BMJ. 2009;338(338):b1773.
   PubMedGoogle Scholar
• Perez-Jorge C, Gomez-Barrena E, Horcajada JP, et al. Drug treatments for prosthetic joint infections in the era of multidrug resistance. Expert Opin Pharmacother. 2016 Jun;17(9):1233–1246.
   PubMed Web of Science ®Google Scholar
• Wooten JM. Pharmacotherapy considerations in elderly adults. South Med J. 2012 Aug;105(8):437–445.
   PubMed Web of Science ®Google Scholar
• Corsonello A, Onder G, Maggio M, et al. Medications affecting functional status in older persons. Curr Pharm Des. 2014;20(19):3256–3263.
   PubMed Web of Science ®Google Scholar
• Murakami T. Absorption sites of orally administered drugs in the small intestine. Expert Opin Drug Discov. 2017;Dec;12(12):1219–1232.
   PubMed Web of Science ®Google Scholar
• Bellmann-Weiler R, Weiss G. Pitfalls in the diagnosis and therapy of infections in elderly patients – a mini-review. Gerontology. 2009;55(3):241–249.
   PubMed Web of Science ®Google Scholar
• Douros A, Grabowski K, Stahlmann R. Safety issues and drug-drug interactions with commonly used quinolones. Expert Opin Drug Metab Toxicol. 2015 Jan;11(1):25–39.
   PubMed Web of Science ®Google Scholar
• Höffken G, Lode H, Prinzing C, et al. Pharmacokinetics of ciprofloxacin after oral and parenteral administration. Antimicrob Agents Chemother. 1985 Mar;27(3):375–379.
   PubMed Web of Science ®Google Scholar
• Gugler R, Allgayer H. Effects of antacids on the clinical pharmacokinetics of drugs. An update. Clin Pharmacokinet. 1990 Mar;18(3):210–219.
   PubMed Web of Science ®Google Scholar
• Colloca G, Santoro M, Gambassi G. Age-related physiologic changes and perioperative management of elderly patients. Surg Oncol. 2010 [Cited 2010 Sept 01];19(3):124–130.
   PubMed Web of Science ®Google Scholar
• Hubbard RE, O’Mahony MS, Woodhouse KW. Medication prescribing in frail older people. Eur J Clin Pharmacol. 2013 [Cited 2013 March 01];69(3):319–326.
   PubMed Web of Science ®Google Scholar
• Hutchison LC, O‘Brien CE. Changes in pharmacokinetics and pharmacodynamics in the elderly patient. J Pharm Pract. 2007;20(1):4–12.
   Google Scholar
• Khan MS, Roberts MS. Challenges and innovations of drug delivery in older age. Adv Drug Deliv Rev. 2018 [Cited 2018 Sept 11];135:3–38.
   PubMed Web of Science ®Google Scholar
• Benson JM. Antimicrobial pharmacokinetics and pharmacodynamics in older adults. Infect Dis Clin North Am. 2017 [Cited 2017 dec 01];31(4):609–617.
   PubMed Web of Science ®Google Scholar
• Giarratano A, Green SE, Nicolau DP. Review of antimicrobial use and considerations in the elderly population. Clin Interv Aging. 2018;13:657–667.
   PubMed Web of Science ®Google Scholar
• Jansen PAF, Brouwers JRBJ. Clinical pharmacology in old persons. Scientifica (Cairo). 2012;2012:78–723678.
   Google Scholar
• Cotreau MM, von Moltke LL, Greenblatt DJ. The influence of age and sex on the clearance of cytochrome P450 3A substrates. Clin Pharmacokinet. 2005 [Cited 2005 Jan 01];44(1):33–60.
   PubMed Web of Science ®Google Scholar
• Cefalu CA. Theories and Mechanisms of Aging. Clin Geriatr Med. 2011;27(4):491–506.
   PubMed Web of Science ®Google Scholar
• Durakovic Z, Vitezic D. Pharmacodynamics and pharmacokinetics in the elderly. Period Biol. 2013;115(4):517–520.
   Web of Science ®Google Scholar
• Thompson CM, Johns DO, Sonawane B, et al. Database for physiologically based pharmacokinetic (PBPK) modeling: physiological data for healthy and health-impaired elderly. J Toxicol Environ Health B Crit Rev. 2009 Jan;12(1):1–24.
   PubMed Web of Science ®Google Scholar
• Benet LZ, Hoener BA. Changes in plasma protein binding have little clinical relevance. Clin Pharmacol Ther. 2002 Mar;71(3):115–121.
   PubMed Web of Science ®Google Scholar
• Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004 Jan;57(1):6–14.
   PubMed Web of Science ®Google Scholar
• Coates P, Daniel R, Houston AC, et al. An open study to compare the pharmacokinetics, safety and tolerability of a multiple-dose regimen of azithromycin in young and elderly volunteers. Eur J Clin Microbiol Infect Dis. 1991 [Cited 1991 Oct 01];10(10):850–852.
   PubMed Web of Science ®Google Scholar
• Shi S, Klotz U. Age-related changes in pharmacokinetics. Curr Drug Metab. 2011 Sep;12(7):601–610.
   PubMed Web of Science ®Google Scholar
• Denic A, Glassock RJ, Rule AD. Structural and functional changes with the aging kidney. Adv Chronic Kidney Dis. 2016;23(1):19–28.
   PubMed Web of Science ®Google Scholar
• Rosini JM, Davis JJ, Muenzer J, et al. High single-dose vancomycin loading is not associated with increased nephrotoxicity in emergency department sepsis patients. Acad Emerg Med. 2016 Jun;23(6):744–746.
   PubMed Web of Science ®Google Scholar
• Hilmer SN. ADME-tox issues for the elderly. Expert Opin Drug Metab Toxicol. 2008 [Cited 2008 Oct 01];4(10):1321–1331.
   PubMed Web of Science ®Google Scholar
• Elinder C-G, Bárány P, Heimbürger O. The use of estimated glomerular filtration rate for dose adjustment of medications in the elderly. Drugs Aging. 2014 [Cited 2014 July 01];31(7):493–499.
   PubMed Web of Science ®Google Scholar
• Reeve E, Trenaman SC, Rockwood K, et al. Pharmacokinetic and pharmacodynamic alterations in older people with dementia. Expert Opin Drug Metab Toxicol. 2017 Jun;13(6):651–668.
   PubMed Web of Science ®Google Scholar
• Sy SKB, Zhuang L, Derendorf H. Pharmacokinetics and pharmacodynamics in antibiotic dose optimization. Expert Opin Drug Metab Toxicol. 2016 [Cited 2016 Jan 02];12(1):93–114.
   PubMed Web of Science ®Google Scholar
• Ambrose PG, Bhavnani SM, Rubino CM, et al. Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it‘s not just for mice anymore. Clinl Infect Dis. 2007;44(1):79–86.
   PubMed Web of Science ®Google Scholar
• Gomez-Romero FJ, Fernandez-Prada M, Navarro-Gracia JF. Prevention of surgical site infection: analysis and narrative review of clinical practice guidelines. Cir Esp. 2017 Nov;95(9):490–502.
   PubMed Web of Science ®Google Scholar
• Ban KA, Minei JP, Laronga C, et al. Executive summary of the American college of surgeons/surgical infection society surgical site infection guidelines-2016 update. Surg Infect (Larchmt). 2017 May;18(4):379–382.
   PubMed Web of Science ®Google Scholar
• Leaper DJ, Edmiston CE. World Health Organization: global guidelines for the prevention of surgical site infection. J Hosp Infect. 2017 Feb;95(2):135–136.
   PubMed Web of Science ®Google Scholar
• Ban KA, Minei JP, Laronga C, et al. American college of surgeons and surgical infection society: surgical site infection guidelines, 2016 update. J Am Coll Surg. 2017 Jan;224(1):59–74.
   PubMed Web of Science ®Google Scholar
• Richmond BK, O‘Brien B, Ubert A, et al. Current treatment guidelines for postoperative surgical site infection: clinical considerations in the surgical care improvement project era. Am Surg. 2015 Apr;81(4):E179–80.
   PubMed Web of Science ®Google Scholar
• Aalirezaie A, Akkaya M, Barnes CL, et al. Proceedings of international consensus meeting on orthopedic infections: general assembly, prevention, operating room environment. J Arthroplasty. 2018 Oct 19;34(2S):S105–S115.
   Google Scholar
• Campoccia D, Montanaro L, Arciola CR. A review of the biomaterials technologies for infection-resistant surfaces. Biomaterials. 2013 Nov;34(34):8533–8554.
   PubMed Web of Science ®Google Scholar
• Campoccia D, Montanaro L, Arciola CR. A review of the clinical implications of anti-infective biomaterials and infection-resistant surfaces. Biomaterials. 2013 Nov;34(33):8018–8029.
   PubMed Web of Science ®Google Scholar
• Romano CL, Malizos K, Capuano N, et al. Does an antibiotic-loaded hydrogel coating reduce early post-surgical infection after joint arthroplasty? J Bone Jt Infect. 2016;1:34–41.
   PubMedGoogle Scholar
• Malizos K, Blauth M, Danita A, et al. Fast-resorbable antibiotic-loaded hydrogel coating to reduce post-surgical infection after internal osteosynthesis: a multicenter randomized controlled trial. J Orthop Traumatol. 2017 Jun;18(2):159–169.
   PubMed Web of Science ®Google Scholar
• Aguilera-Correa JJ, Garcia-Casas A, Jimenez-Morales A, et al. Staphylococcus aureus adherence decrease on hybrid organo-inorganic sol-gel coating. Orthop Proc. 2017;99(Supp 2):89.
   Google Scholar
• Aguilera-Correa JJ, Mediero A, Conesa-Buendia FM, et al. Microbiological and cellular evaluation of fluorine-phosphorus doped titanium alloy: a novel antibacterial and osteostimulatory biomaterial with potential applications in orthopedic surgery. Appl Environ Microbiol. 2019;85(2). pii: e02271-18.
   PubMed Web of Science ®Google Scholar
• Aguilera-Correa JJ, Doadrio AL, Conde A, et al. Antibiotic release from F-doped nanotubular oxide layer on TI6AL4V alloy to decrease bacterial viability. J Mater Sci Mater Med. 2018 Jul 20;29(8):118.
   PubMed Web of Science ®Google Scholar
• Perez-Jorge C, Arenas MA, Conde A, et al. Bacterial and fungal biofilm formation on anodized titanium alloys with fluorine. J Mater Sci Mater Med. 2017 Jan;28(1):8.
   PubMed Web of Science ®Google Scholar
• Lozano D, Hernandez-Lopez JM, Esbrit P, et al. Influence of the nanostructure of F-doped TiO2 films on osteoblast growth and function. J Biomed Mater Res A. 2015 Jun;103(6):1985–1990.
   PubMed Web of Science ®Google Scholar
• Perez-Jorge C, Conde A, Arenas MA, et al. In vitro assessment of Staphylococcus epidermidis and Staphylococcus aureus adhesion on TiO(2) nanotubes on Ti-6Al-4V alloy. J Biomed Mater Res A. 2012 Jul;100(7):1696–1705.
   PubMed Web of Science ®Google Scholar
• Vallet-Regi M, Colilla M, Izquierdo-Barba I. Drug delivery and bone infection. Enzymes. 2018;44:35–59.
   PubMedGoogle Scholar
• Gonzalez B, Colilla M, Diez J, et al. Mesoporous silica nanoparticles decorated with polycationic dendrimers for infection treatment. Acta Biomater. 2018 Mar;1(68):261–271.
   Google Scholar
• Vallet-Regi M, Colilla M, Izquierdo-Barba I, et al. Mesoporous silica nanoparticles for drug delivery: current insights. Molecules. 2017 Dec 25;23(1). pii: E47.
   PubMed Web of Science ®Google Scholar
• Paris JL, Manzano M, Cabanas MV, et al. Mesoporous silica nanoparticles engineered for ultrasound-induced uptake by cancer cells. Nanoscale. 2018 Apr 5;10(14):6402–6408.
   PubMed Web of Science ®Google Scholar
• Martinez-Carmona M, Lozano D, Colilla M, et al. Lectin-conjugated pH-responsive mesoporous silica nanoparticles for targeted bone cancer treatment. Acta Biomater. 2018 Jan;65:393–404.
   PubMed Web of Science ®Google Scholar
• Paris JL, de la Torre P, Victoria Cabanas M, et al. Vectorization of ultrasound-responsive nanoparticles in placental mesenchymal stem cells for cancer therapy. Nanoscale. 2017 May 4;9(17):5528–5537.
   PubMed Web of Science ®Google Scholar
• Gauthier D, Schambach S, Crouzet J, et al. Subcutaneous and intravenous ceftriaxone administration in patients more than 75 years of age. Med Mal Infect. 2014 Jun;44(6):275–280.
   PubMed Web of Science ®Google Scholar
• Borner K, Lode H, Hampel B, et al. Comparative pharmacokinetics of ceftriaxone after subcutaneous and intravenous administration. Chemotherapy. 1985;31(4):237–245.
   PubMed Web of Science ®Google Scholar
• Goutelle S, Valour F, Gagnieu MC, et al. Population pharmacokinetics and probability of target attainment of ertapenem administered by subcutaneous or intravenous route in patients with bone and joint infection. J Antimicrob Chemother. 2018 Apr 1;73(4):987–994.
   PubMed Web of Science ®Google Scholar
• Ferry T, Senechal A, Gagnieu MC, et al. Prolonged subcutaneous high dose (1 g bid) of Ertapenem as salvage therapy in patients with difficult-to-treat bone and joint infection. J Infect. 2012 Dec;65(6):579–582.
   PubMed Web of Science ®Google Scholar
• Frasca D, Marchand S, Petitpas F, et al. Pharmacokinetics of ertapenem following intravenous and subcutaneous infusions in patients. Antimicrob Agents Chemother. 2010 Feb;54(2):924–926.
   PubMed Web of Science ®Google Scholar
• Ferry T, Leboucher G, Fevre C, et al. Salvage debridement, antibiotics and implant retention (“DAIR”) with local injection of a selected cocktail of bacteriophages: is it an option for an elderly patient with relapsing staphylococcus aureus prosthetic-joint infection? Open Forum Infect Dis. 2018 Nov 5;11:ofy269.
   Google Scholar
• Ferry T, Boucher F, Fevre C, et al. Innovations for the treatment of a complex bone and joint infection due to XDR Pseudomonas aeruginosa including local application of a selected cocktail of bacteriophages. J Antimicrob Chemother. 2018 Oct 1;73(10):2901–2903.
   PubMed Web of Science ®Google Scholar
• Saeed K, McLaren AC, Schwarz EM, et al. international consensus meeting on musculoskeletal infection: summary from the biofilm workgroup and consensus on biofilm related musculoskeletal infections. J Orthop Res. 2019 Jan 22. doi: 10.1002/jor.24229. [Epub ahead of print]
   Google Scholar
• Pfang BG, Garcia-Canete J, Garcia-Lasheras J, et al. Orthopedic implant-associated infection by multidrug resistant enterobacteriaceae. J Clin Med. 2019 Feb 8;8(2). pii: E220.
   PubMed Web of Science ®Google Scholar
• Papadopoulos A, Ribera A, Mavrogenis AF, et al. Multidrug-resistant and extensively drug-resistant Gram-negative prosthetic joint infections: role of surgery and impact of colistin administration. Int J Antimicrob Agents. 2019 Mar;53(3):294–301.
   PubMed Web of Science ®Google Scholar